{"TopicDetails": {"type": 0, "ccm2Id": 44098727, "cftId": 0, "identifier": "HORIZON-MISS-2021-UNCAN-01-01", "title": "Preparing UNCAN.eu, a European initiative to understand cancer", "publicationDateLong": 1623801600000, "callIdentifier": "HORIZON-MISS-2021-UNCAN-01", "callTitle": "Preparing UNCAN.eu, a European initiative to understand cancer", "callccm2Id": 44099174, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43108390, "abbreviation": "HORIZON", "description": "Horizon Europe Framework Programme (HORIZON)"}, "programmeDivision": [{"id": 43108557, "abbreviation": "HORIZON.2.1", "description": "Health"}, {"id": 43108541, "abbreviation": "HORIZON.2", "description": "Global Challenges and European Industrial Competitiveness"}], "missionDetails": "<p>The intended goal of the mission on cancer is to save more than three million lives by 2030, with cancer patients living longer and better. The intervention areas include: Understand; Prevent what is preventable; Optimise diagnostics and treatment; Support quality of life; Ensure equitable access in all aforementioned areas. The identified Mission Cancer will address all poorly understood cancers[[Both common and rare cancers or cancer subtypes, at all stages of cancer, any age or part of society.]] in men and women, cancers in children, adolescents/young adults and the elderly, cancers in socio-economically vulnerable people, living in either cities, rural or remote areas, across all Member States and Associated countries.</p>\n\n<p>This would be through a health-in-all policies approach[[Health in All Policies is an approach to public policies across sectors that systematically takes into account the health implications of decisions, seeks synergies, and avoids harmful health impacts in order to improve population health and health equity.&nbsp;<a href=\"https://www.who.int/social_determinants/publications/health-policies-manual/key-messages-en.pdf\">https://www.who.int/social_determinants/publications/health-policies-manual/key-messages-en.pdf</a>]]; through infrastructure support, regional, social and citizen community development; through investments, support and commitments from public and private sources, including from Member States, Associated countries and industry; and through cooperation with third countries.</p>\n\n<p>The identified Mission Cancer is coherent with and will be an essential and integral component of the Europe&rsquo;s Beating Cancer Plan[[<a href=\"https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12154-Europe-s-Beating-Cancer-Plan\">https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12154-Europe-s-Beating-Cancer-Plan</a>]]. It will provide directions and objectives for research and innovation and effective Commission policy to alleviate the burden of cancer.</p>\n\n<p>It also relates to the European Green Deal, including the Farm to Fork strategy[[<a href=\"https://ec.europa.eu/food/farm2fork_en\">https://ec.europa.eu/food/farm2fork_en</a>]]. The mission proposes research and policy directions and objectives to identify effective strategies for the development and implementation of cancer prevention, including on environmental factors (e.g. exposure to workplace carcinogens, air pollution, unhealthy diet, nutrition and low physical activity).</p>\n\n<p>Furthermore, it is also in line with the industrial[[<a href=\"https://ec.europa.eu/info/strategy/priorities-2019-2024/europe-fit-digital-age/european-industrial-strategy_en\">https://ec.europa.eu/info/strategy/priorities-2019-2024/europe-fit-digital-age/european-industrial-strategy_en</a>]] and digitalisation strategy[[<a href=\"https://ec.europa.eu/info/strategy/priorities-2019-2024/europe-fit-digital-age_en\">https://ec.europa.eu/info/strategy/priorities-2019-2024/europe-fit-digital-age_en</a>]]. The mission proposes a further upscaling and digitalisation of services, innovation in diagnostics and interventions, and developing living labs, contributing to the positive impact of efforts by industry and SMEs on the health of citizens. Envisaged opportunities are in the fields of: cancer biomarkers; cloud computing and digital applications, smart apps/sensors; AI/machine learning to facilitate a better understanding of cancer and support, inter alia, screening, administration of combinational therapies, and clinical management of patients living with and after cancer.</p>\n\n<p>Full implementation of the mission is subject to confirmation following the preparatory phase.</p>\n\n<p>Proposals for call(s) and procurement actions under this identified mission should contribute to setting out a credible pathway for a swift implementation of the Mission Cancer, thereby contributing to the envisaged mission goal.</p>\n", "missionDescription": "Mission: Cancer", "topicMGAs": [], "tags": ["in vitro models", "technologies", "social innovation", "cancer communities", "private investors", "metastasis", "IT networks", "ex vivo models", "cloud computing", "refractory cancers", "artificial intelligence", "patient advocacy", "rare cancers", "immune system", "data exchange", "citizen engagement", "innovation", "quality of life", "childhood cancers", "high-throughput data", "member states", "regions", "biological readouts", "databases", "in vivo models", "metadata", "translational cancer research", "animal models", "common cancers", "spin off companies", "national cancer plan", "biomarkers", "neglected cancers", "tumour microenvironment", "in silico models", "patents", "innovators", "repositories", "infrastructure", "registries", "poorly understood cancers", "cancer of unknown primary", "preclinical research", "tumour-host interactions"], "keywords": ["EOSC and FAIR data", "Cancer and its biological basis", "Public engagement", "Research to business", "Societal Engagement", "Economic impact", "Business governance", "Gender in health sciences", "Spin-off companies", "Piloting", "Informed consent", "Sociology", "Genetics", "Policy impact", "Democratic engagement and civic participation", "Co-funded European Partnerships", "Biology", "Innovation and diversity (e.g. gender)", "Anticancer therapy", "Societal impact", "Patents", "Quality-of-life", "Social innovation", "International cooperation", "Haematology"], "flags": ["EoscAndFairData", "SocietalEngagement", "PART-COFUND"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "HORIZON-CSA HORIZON Coordination and Support Actions", "typeOfMGA": [{"id": 43027846, "abbreviation": "HORIZON-AG", "description": "HORIZON Action Grant Budget-Based"}]}], "plannedOpeningDate": "22 June 2021", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["20 October 2021"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3351490": [{"action": "HORIZON-MISS-2021-UNCAN-01-01 - HORIZON-CSA HORIZON Coordination and Support Actions", "plannedOpeningDate": "22 June 2021", "deadlineModel": "single-stage", "deadlineDates": ["20 October 2021"], "budgetYearMap": {"2021": 3000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2021"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<p>Project results will contribute to the following expected outcome: a blueprint for the establishment of UNCAN.eu.</p><p>This entails that:</p><ul level=\"0\"><li>Based on an agreed strategic research and innovation agenda, academic and clinical research centres, innovators<sup><a target=_self href=#fn1 id=r1>[1]</a></sup>, Member States and Associated countries including national and regional funding agencies, policy makers, private investors, public and social sector organisations, citizen and patient advocacy organisations, and national/regional health systems, adopt the operational concept for UNCAN.eu described below, and are willing to cooperate and invest both financially and with other resources (in kind, data, knowledge);</li><li>Clear answers on the European-added value, organizational, logistical, financial, and cultural feasibility, utility and sustainability of UNCAN.eu are given.</li> </ul>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>Overall and despite important progress, understanding of cancer remains incomplete, for both common and rare cancers. This requires a new level of investment in innovative research, including high-potential/high-risk projects. Therefore, a Mission on Cancer proposes a Europe-wide platform, UNCAN.eu, utilising existing, relevant research infrastructures and investing in the development of models and technologies interrogating the interactions of poorly understood cancers<sup><a target=_self href=#fn2 id=r2>[2]</a></sup> and their host.</p><p>A fully-fledged UNCAN.eu initiative will:</p><ul level=\"0\"><li>Underpin all future Mission on Cancer priorities that require a better understanding of poorly understood cancers;</li><li>Agree on a strategic research and innovation agenda between afore-mentioned relevant stakeholders</li><li>Integrate innovative models and technologies with longitudinal patient data (e.g. medical images), samples and biomarkers to deliver concrete benefits for people at risk of cancer, living with and after cancer;</li><li>Allow for data interoperability and re-utilisation, while guaranteeing full protection for the data subjects and applying FAIR data principles.</li> </ul><p>A comprehensive understanding of the organizational, logistic, cultural and financial feasibility, utility and sustainability would be necessary before embarking on such an endeavour.</p><p>This coordination and support action aims to develop the operational concept for such an initiative.</p><p>The proposal should address:</p><ul level=\"0\"><li>Integration with ESFRI European Research Infrastructures, European Reference Networks, as well as other international cancer-centred research and data initiatives <span><span><span>(e.g. 1+Million Genomes</span></span></span><sup><a target=_self href=#fn3 id=r3>[3]</a></sup><span>, SPECTA<sup><a target=_self href=#fn4 id=r4>[4]</a></sup>, etc.), as well as data exchange with national cancer data ecosystems;</span></li><li>Sustainable and interoperable data platforms facilitating data access in compliance with data protection legislation and ethical principles, which will be developed in the framework of a future Health Research and Innovation Cloud, a thematic cloud under the European Open Science Cloud (EOSC)<sup><a target=_self href=#fn5 id=r5>[5]</a></sup>, which will also address the data requirements of the European Health Data Space (EHDS)<sup><a target=_self href=#fn6 id=r6>[6]</a></sup> and be interoperable with it;</li><li>Integration with other platforms proposed under the Mission on Cancer and the Europe\u2019s Beating Cancer Plan, such as a network of comprehensive cancer infrastructures and a virtual European cancer patient digital centre;</li><li>Mechanisms for determining clinical priorities and development of new models and technologies to interrogate the interactions of cancers and their host;</li><li>Mechanisms for regular training on operating the UNCAN.eu platform as well as data management to all data holders and users;</li><li>Potential links with Horizon Europe health cluster partnerships, in particular: the Innovative Health Initiative; the partnership on Personalised Medicine; the Transformation of Health and Care Systems partnership as well as the partnership on Rare Diseases and the Partnership for the Assessment of Risk from Chemicals.</li><li>Providing a mechanism for regular consultation with EU regions, Member States and Associated countries, who should be engaged from the early steps of development;</li><li>Potential links with EU4Health actions relevant for cancer;</li><li>Links to federated data spaces of genomic data and medical images under the Digital Europe programme;</li><li>Equitable access. Broad representation, in particular of less-developed regions or regions from countries striving to boost their research and innovation potential, is highly encouraged;</li><li>Engagement with citizen and patient advocacy organisations;</li><li>Utility, feasibility, sustainability;</li><li><span style=\"color:#333333;\"><span><span>Due consideration to newly EU-funded initiatives such as HealthyCloud, EOSC-Life and the EHDS Joint Action. Links with topic HORIZON-INFRA-EOSC-2021-01-07; objectives are encouraged as well as with topic HORIZON-INFRA-SERV-2021-01-02 objectives.</span></span></span></li> </ul>\n<SPAN class=\"topicdescriptionkind\">Cross-cutting Priorities</SPAN>:<p><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=43108390;crossCuttingPriorityCode=EoscAndFairData;sortQuery=sortStatus;orderBy=asc\">EOSC and FAIR data</a><br><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=43108390;crossCuttingPriorityCode=PART-COFUND;sortQuery=sortStatus;orderBy=asc\">Co-funded European Partnerships</a><br><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=43108390;crossCuttingPriorityCode=SocietalEngagement;sortQuery=sortStatus;orderBy=asc\">Societal Engagement</a><br></p>\n<p id=fn1><a  target=_self href=#r1>[1]</a>Innovators turn research results into new and better services and products in order to remain competitive in the global marketplace and improve the quality of life of Europe\u2019s citizens.</p><p id=fn2><a  target=_self href=#r2>[2]</a>Both common and rare cancers, or cancer subtypes, at all stages of cancer, any age or part of society.</p><p id=fn3><a  target=_self href=#r3>[3]</a><span><span><span>https://ec.europa.eu/digital-single-market/en/european-1-million-genomes-initiative</span></span></span></p><p id=fn4><a  target=_self href=#r4>[4]</a><a href=\"https://www.eortc.org/specta/\">https://www.eortc.org/specta/</a></p><p id=fn5><a  target=_self href=#r5>[5]</a><a href=\"https://ec.europa.eu/info/research-and-innovation/strategy/goals-research-and-innovation-policy/open-science/eosc_en\">https://ec.europa.eu/info/research-and-innovation/strategy/goals-research-and-innovation-policy/open-science/eosc_en</a></p><p id=fn6><a  target=_self href=#r6>[6]</a><a href=\"https://ec.europa.eu/health/ehealth/dataspace_en\">https://ec.europa.eu/health/ehealth/dataspace_en</a></p>", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:11.0pt;line-height:115%;&#10;font-family:&quot;Calibri&quot;,sans-serif;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:&#10;Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;&#10;mso-bidi-font-family:&quot;Times New Roman&quot;;mso-bidi-theme-font:minor-bidi;&#10;color:#404040;mso-themecolor:text1;mso-themetint:191;mso-ansi-language:EN-US;&#10;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\">General conditions</span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">1. Admissibility conditions: </span></b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;&#10;mso-bidi-font-weight:bold\">described in </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex A</a></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:&#10;bold\"> and </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex E</a></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:&#10;bold\"> of the Horizon Europe Work Programme General Annexes</span></p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"> 30 pages as</span><span lang=\"EN-US\" style=\"mso-ansi-language:&#10;EN-US\">&nbsp;described in Part B of the Application Form available in the Submission System</span></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\n<p><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">2. Eligible countries: </span></b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">described in </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;&#10;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex B</a></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"> of the Work Programme General Annexes<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\">Horizon Europe Programme Guide</a></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:&#10;EN-US\">.</span></p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">3<span style=\"mso-bidi-font-weight:bold\">. Other eligibility conditions:</span></span></b><span lang=\"EN-US\" style=\"mso-ansi-language:&#10;EN-US\"> described in </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex B</a></span></span><span style=\"mso-ansi-language:EN-US\"> <span lang=\"EN-US\">of the Work Programme General Annexes</span></span></p>\r\n<p>&nbsp;</p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b>4. Financial and operational capacity and exclusion: </b><span style=\"mso-bidi-font-weight:bold\">described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex C</a> of the Work Programme General Annexes</span></p>\r\n<p>&nbsp;</p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"FR-BE\" style=\"mso-ansi-language:FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\r\n<p>&nbsp;</p>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\"><b><span lang=\"EN-US\">Award criteria, scoring and      thresholds</span></b><span lang=\"EN-US\"> are      described in </span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex      D</a></span><span lang=\"EN-US\"> of      the Work Programme General Annexes<o:p></o:p></span></li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\"><b><span lang=\"EN-US\">Submission and evaluation      processes</span></b><span lang=\"EN-US\"> are      described in </span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex      F</a></span><span lang=\"EN-US\"> of      the Work Programme General Annexes and the </span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\">Online      Manual</a><span lang=\"EN-US\"><o:p></o:p></span></li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\"><b><span lang=\"EN-US\">Indicative timeline for      evaluation and grant agreement: </span></b><span lang=\"EN-US\">described in </span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex      F</a></span><span lang=\"EN-US\"> of the Work Programme General Annexes</span><span lang=\"EN-US\"><o:p></o:p></span></li>\r\n</ul>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">6. Legal and financial set-up of the grants: </span></b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">described in </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex G</a></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"> of the Work Programme General Annexes<o:p></o:p></span></p>\r\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\">Documents<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">Call documents:<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:bold\">Standard application form &mdash;<i style=\"mso-bidi-font-style:normal\"> call-specific application form is available in the Submission System</i><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-csa_en.pdf\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\">Standard application form (HE CSA)</span></a><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\"><o:p></o:p></span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US;mso-bidi-font-weight:bold\">MGA</span><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:&#10;191.4pt\"><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-weight:bold\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf\">HE <span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">General MGA v1.0</span></a></span></span><span class=\"MsoHyperlink\"><span style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:&#10;bold\"> <span lang=\"EN-US\"><o:p></o:p></span></span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:&#10;191.4pt\">&nbsp;</p>\r\n<p>&nbsp;</p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\">Additional documents:<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-1-general-introduction_horizon-2021-2022_en.pdf\">HE Main Work Programme 2021&ndash;2022 &ndash; 1. General Introduction</a><span class=\"MsoHyperlink\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-12-missions_horizon-2021-2022_en.pdf\">HE Main Work Programme 2021&ndash;2022 &ndash; 12. Missions</a><span class=\"MsoHyperlink\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">HE Main Work Programme 2021&ndash;2022 &ndash; 13. General Annexes</a><span class=\"MsoHyperlink\"><span style=\"color: rgb(64, 64, 64);\"><o:p></o:p></span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\">HE Programme Guide</a><span class=\"MsoHyperlink\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\"><span lang=\"EN-US\">EU Financial Regulation</span></a><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/rules-lev-lear-fca_en.pdf\">Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment</a><span class=\"MsoHyperlink\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/aga_en.pdf\"><span lang=\"EN-US\">EU Grants AGA </span>&mdash; Annotated Model Grant Agreement</a> <o:p></o:p></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Funding &amp; Tenders Portal Online Manual</span></a><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/tc_en.pdf\">Funding &amp; Tenders Portal Terms and Conditions</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-size:11.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;&#10;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:&#10;minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:&quot;Times New Roman&quot;;&#10;mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-GB;mso-fareast-language:&#10;EN-US;mso-bidi-language:AR-SA\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/privacy-statement_en.pdf\">Funding &amp; Tenders Portal Privacy Statement</a></span></p>", "supportInfo": "<p><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;font-weight:normal;mso-bidi-font-weight:bold\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><b>Online Manual&nbsp;</b></a></span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">is your guide on the procedures from proposal submission to managing your grant.<o:p></o:p></span></p>\r\n<p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Horizon Europe Programme Guide</span></b></a><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;</span></strong><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif; font-weight: normal;\">contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;type=undefined;categories=;programme=H2020;actions=;keyword=\" target=\"_blank\">Funding &amp; Tenders Portal FAQ</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/research-and-innovation/contact/research-enquiry-service_en\" target=\"_blank\">Research Enquiry Service</a></span>&nbsp;</b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.<o:p></o:p></span></p>\r\n<p><a href=\"https://een.ec.europa.eu/\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Enterprise Europe Network</span></b></a><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;color:#003366\">&nbsp;</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" target=\"_blank\">IT Helpdesk</a></span></b>&nbsp;</span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash;&nbsp;contact the Funding &amp; Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://www.iprhelpdesk.eu/\" target=\"_blank\">European IPR Helpdesk</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;assists you on intellectual property issues.<br />\r\n<br />\r\n</span><b><a href=\"mailto:research@cencenelec.eu\" target=\"_blank\">CEN-CENELEC Research Helpdesk</a> and <a href=\"https://www.etsi.org/research/helpdesk\" target=\"_blank\">ETSI Research Helpdesk</a></b>&nbsp;<span style=\"font-family: Arial, sans-serif;\">&ndash;&nbsp;&nbsp;</span>the European Standards Organisations&nbsp;advise you how to tackle standardisation in your project proposal.&nbsp;&nbsp;</p>\r\n<p class=\"MsoNormal\" style=\"margin-left:36.0pt\"><o:p></o:p></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://euraxess.ec.europa.eu/sites/default/files/am509774cee_en_e4.pdf\" target=\"_blank\">The European Charter for Researchers and the Code of Conduct for their recruitment</a></span></b></span><strong><u><span style=\"font-size:&#10;9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366\"> </span></u></strong><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366;font-weight:&#10;normal;mso-bidi-font-weight:bold\">&ndash; consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.</span></strong><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></b></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/partner-search\" target=\"_blank\">Partner Search Services</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;help you find a partner organisation for your proposal.<o:p></o:p></span></p>\r\n<p>&nbsp;</p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Jun 23, 2021 9:50:08 AM", "lastChangeDate": "Jun 23, 2021 9:50:08 AM", "content": "The submission session is now available for: HORIZON-MISS-2021-UNCAN-01-01(HORIZON-CSA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}